Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration

C-X-C Chemokine Receptor 4 (CXCR4) is widely overexpressed in various types of Cancer and is involved in several Cancer phenotypes including tumor growth, survival, and metastasis. The roles of histamine and Histamine Receptor H1 (HRH1) in Cancer pathogenesis remain controversial. Here, we show that HRH1 is widely expressed in various Cancer cell lines and Cancer tissues and that coexpression of CXCR4 and HRH1 is associated with poor prognosis in breast Cancer. Using bimolecular fluorescence complementation and bioluminescence resonance energy transfer donor saturation assays, we demonstrate that CXCR4 and HRH1 can assemble into a heteromeric complex. Simultaneous activation of CXCR4 and HRH1 synergistically increases calcium flux in MDA-MB-231 cells that endogenously express CXCR4 and HRH1 but not in cells deficient in CXCR4 or HRH1. Costimulation of CXCR4 and HRH1 also significantly enhances CXCL12-induced MDA-MB-231 cell migration, while histamine alone does not induce cell migration. Synergistic effects on calcium flux and cell migration are inhibited by the Gα_i inhibitor pertussis toxin and the Gα_q inhibitor YM254890, suggesting that the Gα_i and Gα_q pathways are involved in the synergy. Enhanced calcium signaling and cell migration are also observed in NCI-H23 and HeLa cells, which coexpress CXCR4 and HRH1. Taken together, our findings demonstrate an interplay between CXCR4 and HRH1, and suggest the possibility of the CXCR4-HRH1 heteromer as a potential therapeutic target for Anticancer therapy.